Cargando…

RAS MAPK inhibitors deregulation in leukemia

Detalles Bibliográficos
Autores principales:	Pasmant, Eric, Vidaud, Dominique, Ballerini, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741395/ https://www.ncbi.nlm.nih.gov/pubmed/26909356

Ejemplares similares

Neurofibromatosis Type 1 Molecular Diagnosis: The RNA Point of View
por: Pasmant, Eric, et al.
Publicado: (2016)

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
por: Masliah-Planchon, Julien, et al.
Publicado: (2015)

KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
por: Vendramini, Elena, et al.
Publicado: (2022)

Ras-Mediated Deregulation of the Circadian Clock in Cancer
por: Relógio, Angela, et al.
Publicado: (2014)

Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities
por: Gilbert-Dussardier, Brigitte, et al.
Publicado: (2016)

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function
por: Braun, Till, et al.
Publicado: (2023)

Deregulation of the CDX2-KLF4 axis in acute myeloid leukemia and colon cancer
por: Rouhi, Arefeh, et al.
Publicado: (2013)

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia
por: Huang, Xiaomeng, et al.
Publicado: (2016)

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
por: Zhang, Qi, et al.
Publicado: (2022)

NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation
por: Lobón-Iglesias, María Jesús, et al.
Publicado: (2019)

Sotos Syndrome Is Associated with Deregulation of the MAPK/ERK-Signaling Pathway
por: Visser, Remco, et al.
Publicado: (2012)

Direct Ras G12C inhibitors: crossing the rubicon
por: Lindsay, Colin R., et al.
Publicado: (2019)

miRNA-mediated deregulation in leukemia
por: Dell’Aversana, Carmela, et al.
Publicado: (2012)

Deregulation of the non-coding genome in leukemia
por: Teppo, Susanna, et al.
Publicado: (2017)

Gene enhancer deregulation and epigenetic vulnerability
por: Lu, Rui, et al.
Publicado: (2016)

Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
por: Zhang, Qi, et al.
Publicado: (2022)

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
por: Martin-Lorenzo, Marta, et al.
Publicado: (2017)

Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling
por: Umstead, MaKendra, et al.
Publicado: (2017)

KSR induces RAS‐independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors
por: Paniagua, Guillem, et al.
Publicado: (2022)

Deregulation of Cell Death in Cancer: Recent Highlights
por: Carafa, Vincenzo, et al.
Publicado: (2020)

Oncogenic Deregulation of Cell Adhesion Molecules in Leukemia
por: Windisch, Roland, et al.
Publicado: (2019)

Author Correction: Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
por: Martin-Lorenzo, Marta, et al.
Publicado: (2018)

Ras in epidermal proliferation
por: Drosten, Matthias, et al.
Publicado: (2014)

K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Deregulation of allopathic prescription and medical practice in India: Benefits and pitfalls
por: Kumar, Raman, et al.
Publicado: (2016)

MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis
por: Masliah-Planchon, Julien, et al.
Publicado: (2013)

Deregulated Ras and Rap1 signaling in rheumatoid arthritis T cells leads to persistent production of free radicals
por: Remans, PHJ, et al.
Publicado: (2002)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

RasGrf1 and Aging
por: Davies, Kelvin J. A., et al.
Publicado: (2011)

Brain RAS: Hypertension and Beyond
por: de Gasparo, Marc, et al.
Publicado: (2013)

S-nitrosylation of Ras in breast cancer
por: Marshall, Harvey E, et al.
Publicado: (2012)

The Ras/MAPK Pathway Is Required for Generation of iNKT Cells
por: Hu, Taishan, et al.
Publicado: (2011)

Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling
por: Chen, Zhiguo, et al.
Publicado: (2020)

Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia
por: Ng, O H, et al.
Publicado: (2014)

Mechanisms underlying transcription factor deregulation in acute lymphoblastic leukemia
por: Cools, Jan
Publicado: (2018)

Deregulated Notch and Wnt signaling activates early-stage myeloid regeneration pathways in leukemia
por: Kang, Yoon-A, et al.
Publicado: (2019)

Oncogenic Ras deregulates cell-substrate interactions during mitotic rounding and respreading to alter cell division orientation
por: Ganguli, Sushila, et al.
Publicado: (2023)

Systemic Regulation of RAS/MAPK Signaling by the Serotonin Metabolite 5-HIAA
por: Schmid, Tobias, et al.
Publicado: (2015)

Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis
por: Mittal, Suruchi, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_u7vja2kcu31lb11votkd5m2bcc